In this episode, Drs. Matt Martinez and Theodore Abraham discuss
“What the Clinician Should Know About the Cardiac Myosin Inhibitor
Mavacamten” for the treatment of hypertrophic cardiomyopathy, and
its mechanisms of action.
About the Podcast
This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.